Bio Nucleus Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -22.73%
- Profit Growth 146.96%
- Ebitda 41.51%
- Net Worth 1.30%
- Total Assets -21.18%
About Bio Nucleus Pharmaceuticals
Bio Nucleus Pharmaceuticals Private Limited (BNPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 January 2015 and has a history of Ten years and one month. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Supriya Verma and Kumar Prashant serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33110DL2015PTC275677
- Company No.
275677
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Bio Nucleus Pharmaceuticals Private Limited
Explore comprehensive data for Bio Nucleus Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Bio Nucleus Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Supriya Verma  | Director | 30-Sep-2021 | Current |
| Kumar Prashant | Director | 01-Feb-2018 | Current |
Financial Performance of Bio Nucleus Pharmaceuticals.
Bio Nucleus Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 22.73% decrease. The company also saw a substantial improvement in profitability, with a 146.96% increase in profit. The company's net worth moved up by a moderate rise of 1.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bio Nucleus Pharmaceuticals?
In 2018, Bio Nucleus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Adventure Turnkey Solutions Private LimitedSupriya Verma is a mutual person
- Dream Holiday Solutions Private Limited
Supriya Verma is a mutual person
- Karna's Foundation
Supriya Verma is a mutual person
- Byder Solutions Private Limited
Kumar Prashant is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bio Nucleus Pharmaceuticals?
Unlock and access historical data on people associated with Bio Nucleus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bio Nucleus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio Nucleus Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Bio Nucleus Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Bio Nucleus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Bio Nucleus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Director Appointment
Supriya Verma was appointed as a Director was appointed as a Director on 30 Sep 2021 & has been associated with this company since 3 years 5 months .
- Director Appointment
Kumar Prashant was appointed as a Director was appointed as a Director on 01 Feb 2018 & has been associated with this company since 7 years 1 month .
- Company Incorporation
Bio Nucleus Pharmaceuticals Private Limited was registered on 19 Jan 2015 with Roc Delhi & aged 10 years 1 month as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Bio Nucleus Pharmaceuticals Private Limited?
Bio Nucleus Pharmaceuticals Private Limited was incorporated on 19 Jan 2015.
What is authorized share capital and paid-up capital of Bio Nucleus Pharmaceuticals Private Limited?
The authorized share capital of Bio Nucleus Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Bio Nucleus Pharmaceuticals Private Limited?
Currently 2 directors are associated with Bio Nucleus Pharmaceuticals Private Limited.
- Supriya Verma
- Kumar Prashant
What is the registered address of Bio Nucleus Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Bio Nucleus Pharmaceuticals Private Limited is D-2/144 Plot No-144 Upper G/Floor Gali No-3 Kh No-720/590, Mahavir Enclav E India, New Delhi, 110045.
What is the corporate identification number (CIN) and company number of Bio Nucleus Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Bio Nucleus Pharmaceuticals Private Limited is U33110DL2015PTC275677 and the company number is 275677 as per Ministry of Corporate Affairs (MCA).
What is the official website of Bio Nucleus Pharmaceuticals Private Limited?
The Official website of Bio Nucleus Pharmaceuticals Private Limited is https://www.bionucleuspharma.com
What has been the recent revenue trend for Bio Nucleus Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2020, the revenue trend for Bio Nucleus Pharmaceuticals Private Limited has fallen by -22.73%.
What change has been observed in the net worth of Bio Nucleus Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2020 indicates that The net worth of Bio Nucleus Pharmaceuticals Private Limited has experienced an upsurge of 1.30%.
When was the last Balance Sheet of Bio Nucleus Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Bio Nucleus Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Suraj VermaDirector
Shyam LalDirector
Kumar SamarAdditional Director
Gaurav KarnaDirectorRC
Rajiv ChhikaraDirector